multi source·5h ago·3 sources analyzed
FDA faces leadership changes as top drug regulator departs
The Food and Drug Administration experiences significant leadership turnover with the departure of its top drug regulator. This follows the recent resignation of the agency's chief. (sources: theguardian, cbsnews, nbcnews)
Image: nbcnews
ModernAction Briefing
Dr. Tracy Beth Høeg has left her position as the FDA's top drug regulator, claiming she was fired after refusing to resign. Her departure adds to the recent shake-up within the agency's leadership.
- Dr. Tracy Beth Høeg was the acting drug chief at the FDA.
- She oversaw the division responsible for regulating prescription and over-the-counter drugs.
- Høeg's departure follows the resignation of the FDA's chief.
Why it matters
The changes in leadership at the FDA may impact the agency's regulatory processes and public confidence in its operations.
Action context
No specific legislation identified for action yet.